20 AIDX SEC Filings

NASDAQ AIDX
$0.26 0.00 (-1.86%)
As of: Oct 22, 2026 · 10:10 AM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing 20/20 Biolabs, Inc. (AIDX) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1PRE 14AOthers0001213900-26-107251Oct 6, 2026 4:33 PM
28-KCurrent Report0001213900-26-101405Sep 18, 2026 8:05 PM
38-KCurrent Report0001213900-26-098792Sep 10, 2026 8:10 PM
48-KCurrent Report0001213900-26-096743Sep 2, 2026 4:32 PM
5DEFA14AOthers0001213900-26-091729Aug 19, 2026 8:50 PM
68-KCurrent Report0001213900-26-091438Aug 19, 2026 1:19 PM
7424B3Prospectus0001213900-26-090765Aug 17, 2026 4:14 PM
8424B3Prospectus0001213900-26-090758Aug 17, 2026 4:10 PM
98-KCurrent Report0001213900-26-090746Aug 17, 2026 4:05 PM
1010-QQuarterly & Annual Report0001213900-26-090042Aug 14, 2026 8:07 PM
118-KCurrent Report0001213900-26-085514Aug 5, 2026 12:00 PM
128-KCurrent Report0001213900-26-080432Jul 22, 2026 8:45 PM
138-KCurrent Report0001213900-26-074182Jul 1, 2026 7:28 PM
14DEFA14AOthers0001213900-26-071173Jun 23, 2026 9:02 PM
15DEF 14AOthers0001213900-26-071172Jun 23, 2026 9:02 PM
16PRE 14AOthers0001213900-26-063543Jun 1, 2026 8:40 PM
178-KCurrent Report0001213900-26-061039May 26, 2026 4:28 PM-
18424B3Prospectus0001213900-26-060048May 21, 2026 8:11 PM
19424B3Prospectus0001213900-26-060045May 21, 2026 8:09 PM
2010-QQuarterly & Annual Report0001213900-26-059542May 20, 2026 8:18 PM
218-KCurrent Report0001213900-26-059526May 20, 2026 8:10 PM
22NT 10-QQuarterly & Annual Report0001213900-26-057812May 15, 2026 8:20 PM
23424B3Prospectus0001213900-26-048270Apr 28, 2026 11:59 AM
24424B3Prospectus0001213900-26-048270Apr 28, 2026 11:59 AM
25424B3Prospectus0001213900-26-048270Apr 28, 2026 11:59 AM
26424B3Prospectus0001213900-26-048269Apr 28, 2026 11:57 AM
27424B3Prospectus0001213900-26-048269Apr 28, 2026 11:57 AM
28424B3Prospectus0001213900-26-048269Apr 28, 2026 11:57 AM
298-KCurrent Report0001213900-26-048257Apr 28, 2026 11:43 AM
308-KCurrent Report0001213900-26-048257Apr 28, 2026 11:43 AM
318-KCurrent Report0001213900-26-048257Apr 28, 2026 11:43 AM
32424B3Prospectus0001213900-26-043009Apr 13, 2026 8:29 PM
33424B3Prospectus0001213900-26-043007Apr 13, 2026 8:28 PM
34EFFECTOthers9999999995-26-001159Apr 10, 2026 4:15 AM
35EFFECTOthers9999999995-26-001126Apr 9, 2026 4:15 AM
364Insider Transaction0001213900-26-040583Apr 6, 2026 9:56 PM
374Insider Transaction0001213900-26-040583Apr 6, 2026 9:56 PM
384Insider Transaction0001213900-26-040583Apr 6, 2026 9:56 PM
394Insider Transaction0001213900-26-040581Apr 6, 2026 9:56 PM
404Insider Transaction0001213900-26-040581Apr 6, 2026 9:56 PM
414Insider Transaction0001213900-26-040581Apr 6, 2026 9:56 PM
42S-1Prospectus0001213900-26-040553Apr 6, 2026 9:28 PM
43POS AMOthers0001213900-26-040545Apr 6, 2026 9:21 PM
448-KCurrent Report0001213900-26-037770Apr 1, 2026 11:22 PM
4510-KQuarterly & Annual Report0001213900-26-037667Mar 31, 2026 9:26 PM
46SCHEDULE 13GBeneficial Ownership Report0001213900-26-025773Mar 10, 2026 9:18 PM
47SCHEDULE 13GBeneficial Ownership Report0001213900-26-025773Mar 10, 2026 9:18 PM
48SCHEDULE 13GBeneficial Ownership Report0001213900-26-025773Mar 10, 2026 9:18 PM
49SCHEDULE 13DBeneficial Ownership Report0001213900-26-025764Mar 10, 2026 9:14 PM
50SCHEDULE 13DBeneficial Ownership Report0001213900-26-025764Mar 10, 2026 9:14 PM

20/20 Biolabs, Inc. SEC Filings API

Pull 20/20 Biolabs, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=AIDX&formtype=10-K,10-Q&api_key=YOUR_API_KEY